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Background The global prevalence of chronic obstructive pulmonary dis-
ease (COPD) has increased markedly in recent decades. Given the scarcity of 
resources available to address global health challenges and respiratory med-
icine being relatively under-invested in, it is important to define research 
priorities for COPD globally. In this paper, we aim to identify a ranked set of 
COPD research priorities that need to be addressed in the next 10 years to 
substantially reduce the global impact of COPD.
Methods We adapted the Child Health and Nutrition Research Initiative 
(CHNRI) methodology to identify global COPD research priorities.
Results 62 experts contributed 230 research ideas, which were scored by 34 
researchers according to six pre-defined criteria: answerability, effectiveness, 
feasibility, deliverability, burden reduction, and equity. The top-ranked re-
search priority was the need for new effective strategies to support smoking 
cessation. Of the top 20 overall research priorities, six were focused on feasi-
ble and cost-effective pulmonary rehabilitation delivery and access, particu-
larly in primary/community care and low-resource settings. Three of the top 
10 overall priorities called for research on improved screening and accurate 
diagnostic methods for COPD in low-resource primary care settings. Further 
ideas that drew support involved a better understanding of risk factors for 
COPD, development of effective training programmes for health workers and 
physicians in low resource settings, and evaluation of novel interventions to 
encourage physical activity.
Conclusions The experts agreed that the most pressing feasible research 
questions to address in the next decade for COPD reduction were on preven-
tion, diagnosis and rehabilitation of COPD, especially in low resource set-
tings. The largest gains should be expected in low- and middle-income coun-
tries (LMIC) settings, as the large majority of COPD deaths occur in those 
settings. Research priorities identified by this systematic international process 
should inform and motivate policymakers, funders, and researchers to sup-
port and conduct research to reduce the global burden of COPD.
Cite as: Adeloye D, Agarwal D, Barnes PJ, Bonay M, van Boven JF, Bryant J, Caramori G, Dockrell D, D’Urzo A, Ekström M, 
Erhabor G, Esteban C, Greene CM, Hurst J, Juvekar S, Khoo EM, Ko FW, Lipworth B, López-Campos JL, Maddocks M, Mannino 
DM, Martinez FJ, Martinez-Garcia MA, McNamara RJ, Miravitlles M, Pinnock H, Pooler A, Quint JK, Schwarz P, Slavich GM, 
Song P, Tai A, Watz H, Wedzicha JA, Williams MC, Campbell H, Sheikh A, Rudan I. Research priorities to address the global 
burden of chronic obstructive pulmonary disease (COPD) in the next decade. J Glob Health 2021,11:15003.
It is estimated that between 300 and 400 million people globally live with chron-
ic obstructive pulmonary disease (COPD) [1,2]. The growing burden of COPD is 
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creasing rates of smoking, household- and ambient air pollution and other exposures, coupled with large and 
ageing populations [3-5]. Furthermore, the ongoing COVID-19 pandemic highlighted COPD as a condition 
that predisposes to increased risk of hospitalisation and death [6]. Given the scarcity of resources available 
for addressing global health challenges and respiratory medicine being relatively underinvested in, it is im-
portant to define research priorities for COPD globally [7-9].
COPD now ranks as the fourth leading cause of death, resulting in around three million deaths each year 
[8,10-12]. Globally, COPD is estimated to result in economic costs of US$2.1 trillion, and at least half of these 
costs are now in LMICs [13]. Of this total, an estimated US$1.9 trillion are direct costs such as medical care, 
while US$0.2 trillion are indirect costs such as missed work [14]. These figures are expected to more than 
double by the year 2030 [13]. Therefore, a coordinated global response is needed to effectively address the 
burden of COPD and the very considerable challenges it poses. Prioritising research on COPD could help to 
motivate leaders, researchers and stakeholders. As resources in global health are generally limited, there is 
a need to agree on research priorities to guide policymakers and funding organisations as they work to ad-
vance the COPD research agenda [15,16].
In response to the heightened interest of the international community in non-communicable diseases, several 
efforts have been successfully conducted in the past decade to identify research priorities in various fields of 
global health [17-19]. These initiatives have assisted progress because the process of identification of research 
priorities has informed governments, funding agencies and the private sector on how to prioritise investments 
in a systematic way. There was a need for a transparent, systematic and replicable prioritisation process that 
would be perceived as globally representative and fair. It should involve all relevant stakeholders to mount a 
coordinated international response to the existing complex and sizable challenges in the field of COPD re-
search. The Child Health and Nutrition Research Initiative (CHNRI) method, now the most commonly used 
methodological approach to generate research priorities for medicine and health care, was developed to re-
spond to this need for methodological rigour. It has been successfully used as a tool to assist decision mak-
ing and consensus development in child health and nutrition [20-22] and subsequently been extended to 
numerous other priority-setting exercises [23], including those in research on disability [24], dementia [25], 
global mental health [26] and medication safety [27].
Past research prioritisation exercises conducted in the field of COPD have been insightful, but have used a va-
riety of approaches and methods that fell short of being global, systematic or replicable outside of the specific 
context, or were limited in scope [28-34]. In this paper, we used the CHNRI method [20-22]. We sought to 
identify a ranked set of COPD research priorities that need to be addressed in the next 10 years to substan-
tially reduce the global impact of COPD – on patients, their families and society at large.
METHODS
The CHNRI method
This was a priority-setting study that crowdsourced expert opinion in a systematic way. The CHNRI meth-
od is a systematic, transparent, and democratic approach to priority setting for research and health inter-
ventions based on collective opinion. It employs the principle of crowdsourcing to collate and score research 
ideas against a pre-defined set of criteria. Based on submitted opinions of a larger number of experts, funders 
and policymakers are able to view the strengths, weaknesses, and relative ranking of each proposed research 
idea. While it allows researchers to independently generate and score research questions, it also involves rel-
evant stakeholders, including patients, carers and support groups, at an early stage of the process, ensuring 
their ownership in the outcomes [35-41]. Previous experiences with more than a 100 conducted CHNRI ex-
ercises are summarized in Box 1.
Management group
We established a Management Group affiliated with National Institute of Health Research's RESPIRE Glob-
al Health Unit and Centre for Global Health at the Usher Institute, the University of Edinburgh, to identify 
research priorities to address the global burden of COPD. In September 2019, we developed a protocol to 
guide this process in line with recently published revised guidelines for the application of the CHNRI meth-
od, based on the experience of its use [35-41]. A small Management Group that includes the authors of this 
report (IR, DA, and AS) coordinated the steps of the priority setting exercise.
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Invitation of experts
We identified 432 experts in COPD research from across the world by searching the Web of Science's Core 
Collection for the most productive authors in the preceding five-year period, or those who were lead authors 
(first, last or corresponding) of the top 1% most cited research articles. Search strategies and selection criteria 
are summarized in Box 1. In the first phase of invitation, e-mails were sent to all the experts seeking their par-
ticipation and with details of the objectives and context of the exercise. In a second e-mail, experts that showed 
interest were invited to generate a minimum of three research questions. The Management Group then scru-
tinised the submitted ideas and ensured that the wording of each idea fitted the format for the scoring process. 
This led to a consolidated list of 230 unique research ideas, that could be categorised in 6 sub-themes (Box 2). 
Then, the experts were re-invited (with a four-week timeline for follow-up) to systematically rank these ideas 
using pre-agreed criteria, which are listed below.
The CHNRI method has been used in over 100 studies led by multilateral organisations (eg, World Health Organization (WHO), United 
Nations Children’s Fund (UNICEF)), national governments (eg, China, India, and South Africa), and funders (eg, The Bill and Melinda 
Gates Foundation) to set research priorities in areas ranging from the reduction of global child mortality, chronic non-communicable dis-
eases or disability to the efficient execution of national health plans [23,35-41]. Previous experiences and statistical simulations found con-
siderable convergence of collective expert opinion leading to stable and replicable results [40].
To conduct this exercise, in September 2019 we ran searches on Web of Science’s Core Collection to identify experts (ie. first, last or cor-
responding lead authors of the top 1% most cited research articles) using the keywords “COPD” or “Chronic Obstructive Pulmonary Dis-
ease”. Then, in January 2020, to put our findings in context of the wider literature, we ran additional searches on MEDLINE, Embase, Glob-
al Health, and CINAHL to identify studies on COPD priority settings published up to December 2019. We used a combination of Medical 
Subject Headings (MeSH) on the databases as follows: “*pulmonary disease, chronic obstructive/ or *bronchitis, chronic/ or *pulmonary 
emphysema/” AND “*morbidity/ or *mortality/ *risk factors/” AND burden adj3 disease” AND “Health Priorit*/ or priority setting*/ or Re-
source allocation/”. No language or geographical restrictions were applied.
Although we took steps to maximise response rate using a three-stage invitation process (initial contact, invitation to submit ideas, and in-
vitation to submit scores), and a follow-up after four weeks for non-response, the overall response rate can be considered quite low, and it 
falls in line invitation to participate in a research without incentives, also observed in previous CHNRI exercises [23-25].
Six broad research sub-themes were identified:
I. Epidemiology and risk factors of COPD (26 research ideas).
II. Aetiology and pathophysiology of COPD and exacerbations (43 research ideas).
III. Strategies (and policies) for prevention, management, and rehabilitation of COPD (92 research ideas).
IV. COPD self-management and adherence to treatment (10 research ideas).
V. Approaches towards improved diagnosis and classification of COPD (44 research ideas).
VI. Monitoring disease progression and/or prognosis of COPD (15 research ideas).
Box 1. Previous CHNRI exercises, search strategy and selection criteria
Box 2. Research sub-themes
Research context and criteria
The context and the criteria for scoring were defined in line with recommendations from the previous exer-
cises and guidelines [38,41]. The context was defined as “global”, ie, taking into account that the majority of 
the burden is in LMICs. The timeframe within which the results were expected from proposed research was 
specified as up to 10 years. The age group of people with COPD was defined as 40 years or older, because the 
management group agreed that the overwhelming majority of COPD cases would be affecting this age group. 
The target population include respiratory physicians, researchers, policymakers, funders, patients and support 
groups across various global settings.
Six independent criteria were agreed by the Management Group and used to discriminate between the many 
proposed research questions identified:
1.  Answerability: Is this research question likely to be answered using the proposed methods and ap-
proaches?
2.  Effectiveness: Is this research question likely to lead to interventions that will effectively reduce the bur-
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3.  Feasibility: Is it feasible to address this research question given the existing level of knowledge, capac-
ity and resources?
4.  Deliverability: Is this research question likely to lead to interventions or solutions that could be readily 
implemented and deliverable to population at scale?
5. Burden reduction: Is this research question likely to lead to a significant reduction in COPD burden?
6. Equity: Is this research question likely to reduce inequity in the population?
Scoring and analysis
All invited contributors were asked to score each submitted research question using these pre-defined crite-
ria. Experts were offered four response options for scoring: 0 (unlikely to meet the criterion); 0.5 (not sure if it 
can meet the criterion); 1 (likely to meet the criterion); or left blank if the expert felt insufficiently informed to 
make a judgment. We generated intermediate scores by calculating the mean of the individual scores for each 
research question and each criterion received from all experts, and it ranged from 0%-100%. Subsequently, 
the overall Research Priority Score (RPS) assigned to each research question was a simple mean of all six cri-
teria-specific scores. Average Expert Agreement (AEA), an indicator of the average proportion of scorers that 
returned the most common answer for a research question was also calculated for each research question to 
provide an understanding of the level of agreement among scorers. This is expressed as the frequency of the 
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where “5” represents the five criteria, and “N” is the total number of experts.
RESULTS
Among the 432 researchers contacted, 64 (14.8%) contributed 264 research questions. We removed the du-
plicates and consolidated the final list into 230 research questions, which were scored by 34 researchers ac-
cording to the six criteria of interest. A total of 8 experts from LMICs accepted our invitation and took part in 
this exercise, although of the initial 432 experts contacted, over 30% were indirectly affiliated or collaborating 
with researchers in LMICs. Further information on the 64 contributors of research questions and 34 among 
them who also agreed to take the time and score is provided in the Online Supplementary Document, in ac-
cordance to General Data Protection Regulation.
Research priority scores and expert agreement
The overall RPS for the 230 research questions ranged from 0.868 (highest) to 0.243 (lowest). The AEA re-
vealed that across the entire exercise, on average, 43%-82% of scorers provided the same most common an-
swer to a criterion related to the 230 proposed research ideas (Supplementary Online Material). The AEA de-
creased with decreasing RPS (Spearman's rho (ρ) = 0.7907, P < 0.001) suggesting a higher degree of agreement 
among experts on the top ranked questions and consistent with previous CHNRI findings. See Tables S1-S7 
in the Online Supplementary Document for RPS and AEA for all 230 research ideas.
Top-ranked priorities
The top-ranked research priority proposed to develop new effective strategies for smoking cessation. Among 
the top 20 overall research priorities, six were focused on feasible and cost-effective pulmonary rehabilitation 
delivery and access, particularly in primary care and low-resource settings. Three of the top 10 overall prior-
ities called for research on improved screening and better diagnostic methods for COPD in primary care and 
low-resource settings. Further ideas that drew support from scorers involved a better understanding of risk 
factors for COPD, development of effective training programmes and guidelines for health workers and phy-
sicians in low resource settings, and encouraging physical activity (Table 1).
Bottom-ranked priorities
Because of very poor scores on one or more of the six criteria, the scorers showed the lowest collective opti-
mism towards ideas that proposed to identify biological pathways that underlie different clinical presentations, 
then exploring if COPD with airway mucus hypersecretion and higher risk of death should be approached 









































www.jogh.org • doi: 10.7189/jogh.11.15003 5 2021  •  Vol. 11  •  15003
as a separate disease and the basis of day-to-day variability in symptoms. Also, there was low optimism to-
wards highly specific questions that sought to provide answers of limited use and transferability or contribute 
to refining the existing definitions of COPD and exacerbation. Interestingly, there was not much support for 
studying gene reprogramming of the epithelium in COPD, piloting replacement of a “COPD” diagnosis with 
individual clinical and biological phenotyping, evaluating the usefulness of measuring sensory and affective 
dimension of acute or episodic breathlessness, or evaluating animal models to determine the contributions of 
a new generation of nicotine products. Finally, the least enthusiasm was shown towards synthesising various 
lines of evidence to reach a consensus whether COPD is a disease or a disorder (Table 2).
Top-ranked priorities across research criteria
When research ideas were considered by their likelihood of answerability, “Studying whether inhaled corti-
costeroids increase risk of bacterial infections in COPD” received the maximum score. For likelihood of effec-
tiveness, there was very high agreement that developing new strategies (including new combinations of phar-
macological and non-pharmacological strategies) to improve smoking cessation would be the most effective 
research idea. Based on the likelihood of feasibility, the leading research idea was improved understanding 
of COPD risk factors and their association with COPD incidence and exact effects, studying whether inhaled 
corticosteroids increase the risk of bacterial infections in COPD, and identifying optimal screening methods 
for COPD in primary care. When likelihood of deliverability was analysed, identifying optimal diagnostic ap-
proaches for COPD in low-resource settings was ranked as most deliverable, followed by identifying optimal 
screening methods for COPD in primary care. The greatest impact on COPD burden was associated with the 
idea of identifying strategies that are effective and cost-effective in reducing anxiety and depression among in-
dividuals with COPD. Finally, most of research ideas in the top 10 when considered by their likelihood of im-
proving equity in the population were focused on low resource settings (Table 3). Please refer to the Online 
Supplementary Document for further details of top-ranked priorities and scores across each of the criteria.
DISCUSSION
Main findings
On the basis of the six suggested criteria, the top priority was focused on finding acceptable, effective and 
cost-effective ways for smoking cessation, which is research in risk reduction. Furthermore, three of the top 
10 overall priorities called for research on improved screening and accurate diagnostic methods for COPD in 
primary care and low resource settings [42]. Moreover, six of the 20 top priorities were focused on feasible 
and cost-effective pulmonary rehabilitation delivery and access, particularly in primary care and low resource 
settings, which highlights the relevance of this exercise for LMICs. Other ideas that drew support from partic-
ipants involved better understanding of risk factors for COPD, development of effective training programmes 
and guidelines for health workers and physicians in low resource settings and encouraging physical activi-
ty. The main output of the CHNRI process is an intuitive list of meaningful research questions provided by a 
group of 34 experts, with 230 research ideas organised and ranked according to explicit priority criteria. The 
COPD experts who took part in this CHNRI exercise concurred that most of these key research questions may 
be successfully answered by 2030.
Findings in the context of the literature
A key difference between this process and those used in other prioritisation exercises, eg, the American Tho-
racic Society/European Respiratory Society statement on research questions in COPD [32] is that, in previous 
attempts to define research priorities, they were not systematically compared. Recommendations for research 
were usually listed as a result of broad overall consensus of participants following the discussion. Furthermore, 
the International Primary Care Respiratory Group (IPCRG) conducted an e-Delphi exercise, where diagnosing 
COPD in a primary care setting was a priority after that survey was completed. A notable difference was that 
community-based pulmonary rehabilitation was lower down the list and there was a separate category for to-
bacco dependence [33].
Meanwhile, in a UK priority setting for respiratory research involving physicians, researchers and profession-
al societies [43], the leading focus leaned towards basic science including lung development and ageing, lung 
injury, repair and regeneration, susceptibility to infections, and sleep apnoea syndromes, which are not in our 
top priorities for reasons already discussed above. In an exercise involving only patients with COPD and asth-
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er priority study among patients mainly emphasized the need to improve the ability to exercise among adults 
living with COPD [45]. Although both patients’ studies [44,45] employed no systematic measure of collating, 
analysing and ranking ideas, their findings reflect in our overall top priorities, and specifically for priorities list-
ed under deliverability which largely focuses on pulmonary rehabilitation and physical activity, and addressing 
screening, diagnosis and treatment in primary care settings to improve outcomes, respectively.
Research and policy implications
The experts agreed that the most pressing feasible research questions to address in the next decade for COPD re-
duction were on prevention, diagnosis and rehabilitation of COPD, especially in low resource settings. This ap-
pears to be in line with a number of recommendations from respiratory experts, giving credence to this exercise. 
For example, in a recent experts’ statement on the top ten research questions for improving COPD care in the next 
decade [46], they proposed exploring impact of new forms of electronic cigarettes on COPD burden, addressing 
challenges with COPD diagnosis, patient’s classification and risk stratification, and improvements in non-pharma-
cologic management particularly pulmonary rehabilitation, as top priorities, which clearly reflect in the our find-
ings and support our recommendations for COPD research in the next decade. Important overall messages from 
the top of the list imply that LMIC settings should increasingly become a priority for research on COPD, because 
large majority of COPD-related deaths in the world today occur there. This implies an increased focus on low-cost 
preventive diagnostic and therapeutic measures, including tobacco reduction and increase in physical exercise.
Therefore, research on proper, cost-effective implementation of those measures will become increasingly im-
portant, which will require extensive capacity building in low-resource settings. Such research should be ex-
pected to lead to tailored country guidelines on addressing COPD, which are much needed [47]. Finally, the 
role of stress is still rather uncertain, but certainly worth investigating in future studies (Box 3) [48-50].
Box topic not identified by the CHNRI method, which could be important to investigate for several reasons, is stress. Stress is a well-
known trigger of inflammatory activity [48,49], and affects clinical outcomes in COPD [50], meaning that it is clinically relevant in this 
context, thus making stress a possible treatment target that could have benefits for COPD and beyond. Meanwhile, atmospheric pollu-
tion was broadly ranked as a non-smoking priority in the overall top 10 research priorities and also listed in the top ten by likelihood 
of effectively reducing the burden of COPD over time. However, it may be somewhat surprising that other specific areas of research on 
air quality particularly in LMICs, were not given more priority. After cigarette smoking, using biomass for cooking and the resulting in-
door pollution is a major cause of COPD in less developed countries, where both indoor and outdoor air pollution are a concern worth 
studying further. Also, work on the development of pharmacological treatment or treating exacerbations did not feature prominently. 
Finally, although there were no specific questions about COVID-19 because the protocol for this exercise was developed in September 
2019, the findings would still be relevant, and helpful at a follow-up to this exercise, in view of a likely risk for poor health outcomes 
among COVID-19 patients with COPD and other chronic airways diseases.
Box 3. Possible role of stress
Strengths and limitations
Diverse experts from across the world have come together for the first time to identify research priorities, 
which now need to be built on through strategic research investment in these prioritised areas. Nevertheless, 
some limitations are worth noting. The application of the CHNRI methodology to the field of COPD required 
some contextual adaptations including the experts and the scorers' selection, question consolidation, modi-
fied criteria and scoring processes. Still, it is important to note that the CHNRI methodology was originally 
conceived to be adaptive and has been similarly customised before and used in various settings [23], and our 
adaptations were collectively discussed and agreed upon by the Management Group. Another deviation from 
the prescribed process was lack of involvement from the representatives of the funders from the early stages.
In terms of equity, diversity and inclusivity, we carefully studied if the process inherently biased the outcomes 
against some groups or types of research questions. Table 2 presented research questions that achieved the 
lowest scores. It is clear that highly theoretical work was not favoured in light of the urgent need to address the 
COPD burden globally, especially in LMICs. Besides, the criteria were chosen to prefer research questions that 
are feasible and could realistically address the burden within a decade. This did not favour research questions 
from basic science. This is why the questions at the bottom of the list were often highly specific, or advanced 
research ideas with more “blue-sky” thinking, or they had complex downstream outcomes.
One possible reason that could have disadvantaged highly specific or innovative research questions could be 
that some experts were not necessarily familiar enough with the research area to recognise a potentially feasi-










































2021  •  Vol. 11  •  15003 10 www.jogh.org •  doi: 10.7189/jogh.11.15003
clinical background of the experts affected the results. Furthermore, only COPD researchers were included, 
while other physicians (including those in primary care), nurses, patients, support groups and funding bod-
ies, who are all important stakeholders, were not.
Despite efforts to represent all geographic regions and resource levels, respondents were predominantly COPD 
researchers from developed countries. We note that the South East Asia, African and Eastern Mediterranean 
regions were relatively under-represented. Although this likely reflects the current low levels of COPD research 
and advocacy efforts and potential barriers to participation that may exist in these settings, we acknowledge 
that priorities may vary by culture, region and resource level. This exercise was not able to capture and exam-
ine these differences, and culture and system specific research may be required.
Another important contributing factor for under-representation of LMIC-based researchers is likely the inclu-
sion criterion of very high productivity or citations of their papers, which is difficult for them to achieve given 
limited resources for research, although our initial searches would have returned a sizeable number of research-
ers in HICs who were collaborating with colleagues in LMICs. This indeed reflects in our final top 20 rankings, 
with six focused on feasible and cost-effective pulmonary rehabilitation delivery and access in low resource 
settings, and three of the top 10 calling for research on improved screening and accurate diagnostic methods 
for COPD in primary care and low resource settings, both clearly important needs in LMICs. Moreover, seven 
of the research ideas in the top 10 under the likelihood of improving equity in the population were directly 
focused on LMICs (see Table S6 in the Online Supplementary Document). The drop-out rate from provid-
ing research questions to scoring them was also expected to be quite high. This is common with prioritisation 
exercises based on crowdsourcing, and it should be acknowledged, which was elaborated in Box 1 [23-25].
CONCLUSIONS
Research priorities identified by this systematic international process should inform and motivate policymak-
ers, funders and researchers to support and conduct research to reduce the global burden of COPD. The larg-
est gains should be expected in LMIC settings, as the large majority of COPD deaths occur in those settings 
[51]. The follow-up to this process should identify and map outcomes to currently funded research to high-
light apparent gaps and opportunities for increased investment.
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